Transcription

• Speaker #0

  Smarter test ordering tools for laboratories, new clarity in accreditation checklists, and what's slowing the clinical rollout of artificial intelligence in pathology. Coming up next, This is the Path News Network Daily Edition, powered by the College of American Pathologists. I'm Stevon Burrell. It's Thursday, January 29th, and here are the latest headlines. Smarter test utilization is becoming essential as laboratories work to maintain diagnostic accuracy while managing limited resources. The CAP's test ordering program has expanded with eight new modules and clinician handouts, addressing high-impact testing areas such as autoimmune disease, chronic conditions, and molecular diagnostics. Each module is developed and reviewed by CAP committees and councils to support evidence-based laboratory stewardship. In the weeks ahead, stay tuned for discussions with experts about these modules and their impact on laboratory stewardship and clinical practices. And environmental conditions, specimen handling, and transport processes can directly affect laboratory quality and compliance. In a recent clinical pathology article in CAP Today, updates to the CAP accreditation checklist bring added clarity to requirements involving humidity monitoring, Specimen self-collection, pneumatic tube transport for platelet testing, and non-urine body fluid crystal analysis. Dr. Amer Mahmoud, chair of the CAP Checklist Committee, says self-collection continues to expand across more testing disciplines. Quote, we are seeing a trend of more types of testing beyond the classic ones, like urine and semen analysis, offered with specimen self-collection. In the weeks to come, Stay tuned for discussions with experts about these checklist updates and their impact on laboratory practices. Artificial intelligence is advancing in pathology, but putting algorithms into routine clinical use remains a challenge. In an Information Technology Featured article in CAP Today, experts examine the growing gap between AI development and real-world laboratory implementation. Dr. Carolyn Glass, a member of the CAP Artificial Intelligence Committee, says the bottleneck is no longer algorithm development. Quote, the bottleneck now is the infrastructure required to clinically implement and monitor the safety of these algorithms, as well as the reimbursement structure. Take a digital dive by visiting the link in today's show notes. And finally. A laboratory milestone in Southern California is expanding access to clinical-grade testing. The San Diego Laboratory of Crown Bioscience has earned accreditation from the CAP, booting on its CLIA certification obtained last summer. Julie Mayer, Vice President of the Global Biomarker Platform at Crown Bioscience, says the recognition strengthens the laboratory's clinical capabilities. Quote, With these accreditations in place, we are better positioned to support clinical trials with high-quality, reliable data. That's all we have for today. Check out the show notes for today's topics covered. You can find us on Apple Podcasts, Amazon Music, or Spotify. Subscribe on your favorite platform. Look for more news like this in our weekly newsletters published every Tuesday and Thursday. We'll be back tomorrow at 5 a.m. Eastern with more CAP News. For The Daily Edition. I'm Stevon Burrell. Have a great day.